You have 9 free searches left this month | for more free features.

Condition

Atopic Dermatitis (1)

Chronic Spontaneous Urticaria (1)

Dermatitis, Atopic (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Eli Lilly and Company (3)

Collaborator

Intervention

ly3454738 (3)

placebo (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

ly3454738

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)

Terminated

Chronic Spontaneous Urticaria

LY3454738
Placebo

Bakersfield, California
+24 more

Feb 14, 2022

Atopic Dermatitis Trial in Worldwide (LY3454738, Placebo)

Not yet recruiting

Atopic Dermatitis

LY3454738
Placebo

Fort Smith, Arkansas
+55 more

Jun 12, 2023

Dermatitis, Atopic Trial in Puerto Rico, United States (LY3454738, Placebo)

Completed

Dermatitis, Atopic

LY3454738
Placebo

Anniston, Alabama
+20 more

Oct 5, 2021